VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $9,673,000 | -25.2% | 607,618 | -2.3% | 2.68% | -24.8% |
| Q4 2017 | $12,928,000 | +43.4% | 622,146 | -1.1% | 3.57% | +40.8% |
| Q3 2017 | $9,013,000 | -17.8% | 629,003 | -0.8% | 2.54% | -16.1% |
| Q2 2017 | $10,964,000 | +54.9% | 633,787 | -1.2% | 3.02% | +56.8% |
| Q1 2017 | $7,078,000 | -9.2% | 641,738 | +19.5% | 1.93% | -9.1% |
| Q4 2016 | $7,795,000 | -51.1% | 536,894 | -17.4% | 2.12% | -50.0% |
| Q3 2016 | $15,956,000 | +13.3% | 649,959 | +13.4% | 4.24% | +17.3% |
| Q2 2016 | $14,086,000 | +103.2% | 573,321 | +117.5% | 3.62% | +115.4% |
| Q1 2016 | $6,933,000 | -2.4% | 263,641 | +277.3% | 1.68% | +4.3% |
| Q4 2015 | $7,102,000 | – | 69,874 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |